Today: 9 June 2026
Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”
16 January 2026
2 mins read

Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”

SAN FRANCISCO, Jan 16, 2026, 06:41 PST

  • Huang said no researchers can build a so-called “god AI” with today’s technology.
  • He also pushed back on “doomer” talk and warned against rules that could “suffocate startups.”
  • Nvidia shares were up about 0.9% in early U.S. trading.

Nvidia chief executive Jensen Huang said the tech world is nowhere close to creating a so-called “god AI” — shorthand for a single, all-knowing system that can fully “understand” everything from human language to biology and physics. “I don’t see any researchers having any reasonable ability to create god AI… That god AI just doesn’t exist,” Huang said. TechRadar

The remarks land as companies rush to roll out AI features and build out the computing to run them, while regulators and workers ask the same question in different ways: what happens when the models get stronger, cheaper and more common.

Huang’s voice carries weight because Nvidia’s chips have become a backbone for much of the AI buildout. His view also runs against a louder strand of the conversation that skips from today’s chatbots to omnipotent machines, or to a labor market free-fall.

In a separate interview, Huang called the “doomer narrative” — end-of-the-world talk about AI — “extremely hurtful,” and said it has “done a lot of damage.” He also questioned the push for tighter AI rules from parts of the industry, asking: “Why are they talking to governments about these things to create regulations to suffocate startups?” TweakTown

Huang also tried to reframe the jobs debate with a distinction between “tasks” and “purpose,” arguing AI will chew through repetitive work without wiping out most roles. “I spend most of my day typing,” he said, adding that automating that work lets him do more — “I become more busy because I’m able to do more work.” Business Insider

The same logic applies, he said, in jobs from software engineering to restaurants: even if AI takes an order or drafts code, the core job is still solving problems and being accountable for outcomes.

Huang has used a more sweeping line to describe what he thinks happens next: “Software is eating the world, but AI is going to eat software.” In plain terms, that means the software layer itself changes — less hand-written instruction, more systems that generate, adapt and automate on the fly. The Economic Times

Nvidia shares were up about 0.9% at $188.78 in early trading on Friday.

The company is not alone in trying to steer the narrative. Rivals such as AMD are pushing their own data-center chips, while big tech groups continue to design more silicon in-house to cut costs and reduce reliance on outside suppliers.

But there is an obvious uncertainty: the gap between flashy demos and hard productivity gains, plus the risk that governments clamp down after high-profile failures, misuse, or a wave of AI-linked layoffs. Huang’s argument depends on companies using AI to expand output — not to simply shrink headcount.

For now, he is trying to drag the discussion back to earth: focus on narrow systems that work, don’t sell sci-fi, and don’t pretend “god AI” is next quarter’s product cycle.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees
Previous Story

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus
Next Story

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Go toTop